Pre-procedural Risk Score-Based Endoscopist Assignment for Pain Reduction in Unsedated Colonoscopy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorNingbo No. 1 Hospital

About this trial

This multicenter randomized controlled trial evaluates whether a pre-procedural risk score-based endoscopist assignment strategy reduces intraprocedural pain in high-risk patients undergoing unsedated colonoscopy. High-risk patients (risk score \>5) are randomized 1:1 to either the intervention group (examination performed by expert endoscopists with ≥5,000 colonoscopy experiences) or the control group (examination performed by endoscopists assigned per routine hospital scheduling). The primary outcome is the proportion of patients reporting moderate-to-severe pain during colonoscopy, assessed by a blinded research assistant using a 4-point VRS. A total of 106 high-risk patients will be enrolled from two centers in China.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 18-75 years.

Outpatient or inpatient undergoing colonoscopy for medical screening, polyp surveillance, or polypectomy.

Pre-procedural risk score >5 (based on the following scoring system: BMI <19 [5 points], female sex [1 point], history of abdominal or pelvic surgery [2 points], constipation [3 points]).

Disqualifiers

Patients who have received sedation or analgesia prior to colonoscopy.

Patients unwilling to cooperate or unable to provide informed consent.

Incomplete intestinal obstruction.

Inflammatory bowel disease, multiple polyposis syndromes, or severe chronic cardiac or pulmonary disease.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Risk Score-Based Endoscopist Assignment

    Other intervention

    High-risk patients (pre-procedural risk score \>5) undergoing unsedated colonoscopy are assigned to expert endoscopists who have completed at least 5,000 colonoscopy procedures.

Treatment groups

106 Participants
are divided into 2 treatment groups
Group A: Risk Score-based Endoscopist AssignmentExperimental treatment 1 intervention
Group B: Routine Hospital Scheduling AssignmentNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Proportion of Participants with Moderate-to-Severe Pain During Colonoscopy

Pain intensity is assessed using a VRS-4 ( none, mild, moderate, severe) immediately after the colonoscopy by a research assistant who is blinded to group allocation. Moderate or severe pain is defined as the primary outcome event.

Time frame
Immediately after the colonoscopy procedure

Secondary outcomes

1

Adenoma Detection Rate (ADR)

Proportion of participants with at least one histologically confirmed adenoma detected during colonoscopy. All resected polyps are sent for pathological examination.

Time frame
At the time of colonoscopy (pathology results available within 1 week after procedure)
2

Willingness to Undergo Repeat Unsedated Colonoscopy

Proportion of participants who respond "yes" when asked whether they would be willing to undergo a repeat unsedated colonoscopy in the future.

Time frame
Immediately after the colonoscopy procedure
3

Patient Satisfaction

Patient satisfaction is assessed by a research assistant using a standardized questionnaire, graded as satisfied, fair, or dissatisfied.

Time frame
Immediately after the colonoscopy procedure
4

Cecal Intubation Time

Time from endoscope insertion to successful cecal intubation, measured in minutes.

Time frame
During the colonoscopy procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: